Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jan-Apr;14(1):31-35.

STATINS AND BONE HEALTH: A MINI REVIEW

Leslie R Morse  1   2 , Jennifer Coker  1 , Ricardo A Battaglino  2
Affiliations

STATINS AND BONE HEALTH: A MINI REVIEW

Leslie R Morse et al. Actual osteol. 2018 Jan-Apr.

Abstract
in English, Spanish

Statins are a widely prescribed class of medications that inhibit similar pathways as the anti-resorptive bisphosphonate drugs. Statins target the mevalonate pathway by blocking HMG-CoA reductase. Several recent meta-analyses concluded statins are osteoprotective in the general population. Here we present current literature exploring the mechanisms underlying the putative osteoprotective effects of statins. We also review recent clinical studies, ranging from observational cohort studies to randomized clinical trials, testing the effect of statins on bone health in various populations.

Las estatinas son un grupo de drogas prescriptas en forma habitual, con la capacidad de bloquear vías de señalizaciÓn similares a las inhibidas por los amino-bisfosfonatos. Las estatinas inhiben la vía del mevalonato, a través del bloqueo de diferentes enzimas. Varios metaanálisis recientes llevaron a la conclusión de que las estatinas tienen capacidad osteoprotectora en la población general. En esta revisión presentamos la literatura actual describiendo los mecanismos que subyacen en el potencial efecto osteoprotector de las estatinas, como así también estudios observacionales y clínicos aleatorizados sobre el efecto de estatinas en la salud ósea en diversas poblaciones.

Keywords: bone loss; fracture healing; statins.

PubMed Disclaimer

Conflict of interest statement

Disclosures All authors have no conflicts of interest.

References

    1. Mundy G, Garrett R, Harris S, Chan J, Chen D, Rossini G, et al. Stimulation of bone formation in vitro and in rodents by statins. Science 1999; 286(5446):1946–9. - PubMed
    1. Ghosh-Choudhury N, Mandal CC, and Choudhury GG. Statin-induced Ras activation integrates the phosphatidylinositol 3-kinase signal to Akt and MAPK for bone morphogenetic protein-2 expression in osteoblast differentiation. J Biol Chem 2007; 282(7):4983–93. - PubMed
    1. Ohnaka K, Shimoda S, Nawata H, Shimokawa H, Kaibuchi K, Iwamoto Y, et al. Pitavastatin enhanced BMP-2 and osteocalcin expression by inhibition of Rho-associated kinase in human osteoblasts. Biochem Biophys Res Commun 2001; 287(2):337–42. - PubMed
    1. Ruan F, Zheng Q, and Wang J. Mechanisms of bone anabolism regulated by statins. Biosci Rep 2012; 32(6):511–9. - PMC - PubMed
    1. Woo JT, Kasai S, Stern PH, and Nagai K. Compactin suppresses bone resorption by inhibiting the fusion of prefusion osteoclasts and disrupting the actin ring in osteoclasts. J Bone Miner Res 2000; 15(4):650–62. - PubMed

LinkOut - more resources